Prognostic Significance of Expression of VEGF and Cox-2 in Nasopharyngeal Carcinoma and Its Association With Expression of C-erbB2 and EGFR

被引:28
|
作者
Kim, Tae-Jung [1 ]
Lee, Youn Soo [1 ]
Kang, Jin-Hyung [2 ]
Kim, Yeon-Sil [3 ]
Kang, Chang Suk [1 ]
机构
[1] Catholic Univ Korea, Dept Hosp Pathol, Coll Med, Seoul, South Korea
[2] Catholic Univ Korea, Div Med Oncol, Dept Internal Med, Coll Med, Seoul, South Korea
[3] Catholic Univ Korea, Dept Radiat Oncol, Coll Med, Seoul, South Korea
关键词
nasopharyngeal carcinoma; VEGF; Cox-2; C-erbB2; EGFR; GROWTH-FACTOR-RECEPTOR; SQUAMOUS-CELL CARCINOMA; EPSTEIN-BARR-VIRUS; CYCLOOXYGENASE-2; EXPRESSION; TUMOR ANGIOGENESIS; TREATMENT OUTCOMES; BREAST-CANCER; SURVIVAL; RADIOTHERAPY; COEXPRESSION;
D O I
10.1002/jso.21767
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: This study evaluated several tumor angiogenesis-related markers to examine their expression pattern and relation to clinicopathologic implications of nasopharyngeal carcinoma. Methods: Paraffin sections from 69 nasopharyngeal carcinomas obtained before radiotherapy were prepared. The expression of vascular endothelial growth factor (VEGF), cyclooxygenase-2 (Cox-2), C-erbB2, and epidermal growth factor receptor (EGFR) were investigated by immunohistochemistry and then correlated with various clinicopathologic parameters. Results: VEGF was inversely correlated with C-erbB2 (P = 0.036). In survival analysis, high mitosis (>= 5/10 high power field) was significantly associated with worse relapse-free survival in univariate analysis (P = 0.048) but not in multivariate analysis (P = 0.153). High stage, high mitotic rate, absence of VEGF, and presence of Cox-2 were associated with worse survival in both univariate analysis (P = 0.002, P = 0.038, P = 0.044, and P = 0.028, respectively) and multivariate analysis (P = 0.007, P = 0.036, P = 0.047, and P = 0.004, respectively). Conclusions: Absence of VEGF is a useful indicator of poor prognosis in addition to Cox-2 expression, high stage, and high mitosis. J. Surg. Oncol. 2011; 103: 46-52. (c) 2010 Wiley-Liss, Inc.
引用
收藏
页码:46 / 52
页数:7
相关论文
共 50 条
  • [21] Effect of molecular targeted therapy combined with radio-therapy on the expression and prognostic value of COX-2 and VEGF in bone metastasis of lung cancer
    Hu, Yang
    Ren, Hui
    Yang, Ling
    Jin, Caibao
    Wei, Youying
    JOURNAL OF BUON, 2020, 25 (02): : 811 - 820
  • [22] Expression of COX-2 in Carcinoma Breast
    Sharma, Ashish
    Marwah, Nisha
    Parmar, Padam
    Sen, Rajeev
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2018, 12 (03) : EC10 - EC14
  • [23] Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC)
    Yang, Yu
    Zhu, Jiang
    Gou, Hongfeng
    Cao, Dan
    Jiang, Ming
    Hou, Mei
    MEDICAL ONCOLOGY, 2011, 28 (03) : 796 - 803
  • [24] COX-2 over-expression correlates with VEGF and tumour angiogenesis in canine mammary cancer
    Queiroga, Felisbina L.
    Pires, Isabel
    Parente, Margarida
    Gregorio, Hugo
    Lopes, Carlos S.
    VETERINARY JOURNAL, 2011, 189 (01) : 77 - 82
  • [25] The prognostic significance of COX-2 and survivin expression in ovarian cancer
    Athanassiadou, Pauline
    Grapsa, Dimitra
    Athanassiades, Peter
    Gonidi, Maria
    Athanassiadou, Anna-Maria
    Tsipis, Angelos
    Patsouris, Efstratios
    PATHOLOGY RESEARCH AND PRACTICE, 2008, 204 (04) : 241 - 249
  • [26] Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas
    Lee, Sung Hak
    Lee, Youn Soo
    Hong, Yong Gil
    Kang, Chang Suk
    APMIS, 2014, 122 (01) : 16 - 24
  • [27] The importance of COX-2 expression as prognostic factor in early breast cancer
    Kargi, A.
    Uysal, M.
    Bozcuk, H.
    Coskun, H. S.
    Savas, B.
    Ozdogan, M.
    JOURNAL OF BUON, 2013, 18 (03): : 579 - 584
  • [28] COX-2 expression in uterine carcinosarcoma
    Menczer, Joseph
    Schreiber, Letizia
    Sukmanov, Oleg
    Kravtsov, Vladimir
    Berger, Esther
    Golan, Abraham
    Levy, Tally
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2010, 89 (01) : 120 - 125
  • [29] Prevalence and prognostic significance of COX-2 expression in stage IB cervical cancer
    Manchana, T
    Trratanachat, S
    Sirisabya, N
    Vasuratna, A
    Termrungruanglert, W
    Tresukosol, D
    GYNECOLOGIC ONCOLOGY, 2006, 100 (03) : 556 - 560
  • [30] PROGNOSTIC-SIGNIFICANCE OF C-ERBB-2 EXPRESSION IN INVASIVE DUCTAL CARCINOMA OF THE BREAST
    HORIGUCHI, J
    LINO, Y
    TAKEI, H
    MORISHITA, Y
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1995, 25 (04) : 119 - 123